Building access to the Regenstrief Institute is restricted at least through September 13, 2020. More on our coronavirus precautions.
See our coronavirus precautions.
Dr. Babar Khan gives opening remarks at American Delirium Society 2020 meeting

2020 event co-chaired by Regenstrief researcher scientists

More than 400 people from around the world signed up to attend the American Delirium Society’s 2020 virtual annual meeting. Presenters and participants discussed the latest in delirium research, from diagnosing the acute brain failure to strategies to reduce delirium incidence. The meeting was co-chaired by Babar Khan, M.D., M.S., Regenstrief Institute research scientist, American Delirium Society (ADS) president and Indiana University School of Medicine associate professor and Noll Campbell, PharmD, M.S., Regenstrief research scientist, ADS treasurer and Purdue College of Pharmacy assistant professor.

The annual ADS meeting was scheduled to be held in Indianapolis, but organizers moved it online in light of the COVID-19 pandemic. About three dozen experts presented keynotes and participated in abstract sessions.

More than seven million hospitalized Americans suffer from delirium each year. Delirium is a state of confusion that comes on very suddenly and can last for hours or days. It often leads to longer hospital stays, more complications, higher mortality rates, and dementia or long-term cognitive impairment. It frequently occurs in patients treated in the intensive care unit, especially those who are older than 65.

Delirium is often not diagnosed by the healthcare system, and its impact on patients’ health is often not understood. The ADS works to lead the effort to foster research, education, quality improvement, advocacy and implementation science to minimize the impact of delirium on the health and wellbeing of patients.

“Research and education about delirium is especially important during the COVID-19 pandemic,” said Dr. Khan, who served as ADS president for the 2019-2020 term. “We expect that as more COVID-19 patients are treated in the ICU, many will suffer delirium and will feel its impact in the long-term. The sharing of research and discourse during this conference will help care providers better understand this condition and provide better care for patients.”

Regenstrief Research Scientist and IU School of Medicine Assistant Professor Sikandar Khan, D.O., and IU School of Medicine Administrative Coordinator Makenna Flory assisted with managing the technology during the digital conference.

The Indianapolis ADS meeting has been rescheduled for March 2021.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313
Cindy Fox Aisen
Regenstrief Institute
caisen@regenstrief.org
(317) 843-2275

Related News

Jul 07, 2020 • News
New healthcare codes released, including terms used internationally to track coronavirus
System provides common language for seamless exchange of health data in 179 countries LOINC®, created and maintained by the Regenstrief Institute, is amplifying its global work to help track the coronavirus by releasing new standardized codes for healthcare systems’ laboratory tests, clinical observations and other data. Health systems often have their own format for recording…
Continue Reading >
Jul 06, 2020 • News
During COVID-19 disruption, Regenstrief and CTSI offer free continuing education classes
60 from Notre Dame, IU, Purdue, Duke, Ohio State, Oregon participate Amid the work disruptions from COVID-19, Regenstrief Institute and Indiana Clinical and Translational Sciences Institute (CTSI) are providing free opportunities for research professionals to continue their education. After a successful launch to Regenstrief and Indiana University employees, the institute made classes available to Indiana…
Continue Reading >